MktsMarkets

XBiotech Inc.
NASDAQ: XBITKey statistics
XBIT News
Stories mentioning XBIT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 5,206 | 25,355 | 5,080 | 5,336 | 11,619 | 7,821 | 7,127 | 12,984 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 6,047 | 6,336 | 13,550 | 8,748 | 7,904 | 14,966 | ||
| Operating Income (Loss) | (6,274) | (29,752) | (6,047) | (6,336) | (13,550) | (8,748) | (7,904) | (14,966) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 1,036 | 549.00 | (85.00) | (3.00) | 995.00 | 407.00 | 25.00 | 0.00 |
| Pretax Income | (5,456) | (26,816) | (5,906) | (1,728) | (10,855) | (10,549) | (5,006) | (13,031) |
| Tax Provision | 49.00 | 76.00 | 102.00 | 28.00 | 29.00 | (41.00) | 9.00 | (25.00) |
| Net Income (Loss) | (5,505) | (26,892) | (6,008) | (1,756) | (10,884) | (10,508) | (5,015) | (13,006) |
| Earnings Per Share (Basic) | (0.18) | (0.88) | (0.20) | (0.06) | (0.36) | (0.34) | (0.16) | (0.43) |
| Earnings Per Share (Diluted) | ||||||||
| Weighted Average Shares Outstanding (Basic) | 30,488 | 30,488 | 30,488 | 30,488 | 30,488 | 30,461 | 30,473 | 30,456 |
| Weighted Average Shares Outstanding (Diluted) | ||||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About XBIT
XBiotech Inc. (NASDAQ: XBIT) is a stock listed on the Nasdaq Stock Market under the ticker symbol XBIT. It last traded at $2.05 (Nov 3, 2026, 3:54 PM ET), up 6.8% on the day. That gives XBiotech a market capitalisation of $61.2M.
Over the past 52 weeks XBIT has traded between $1.80 and $3.44.
For the quarter ended Mar 31, 2026 it reported a net loss of $5.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$5.5M |
| Dec 31, 2025 | — | -$26.9M |
| Sep 30, 2025 | — | -$6.0M |
| Jun 30, 2025 | — | -$1.8M |
From XBiotech’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…